Pages that link to "Q81229342"
Jump to navigation
Jump to search
The following pages link to Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma (Q81229342):
Displaying 50 items.
- The vanishing role of whole brain radiotherapy for primary central nervous system lymphoma (Q27025006) (← links)
- Advances in Primary Central Nervous System Lymphoma (Q31007237) (← links)
- Efficacy of Procarbazine, Lomustine, and Vincristine Chemotherapy for Recurrent Primary Central Nervous System Lymphomas (Q33427856) (← links)
- Efficacy and safety of pemetrexed on recurrent primary central nervous system lymphomas in China: a prospective study (Q33714119) (← links)
- High-dose methotrexate and rituximab with deferred radiotherapy for newly diagnosed primary B-cell CNS lymphoma (Q34132988) (← links)
- Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate? (Q34190457) (← links)
- R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma (Q35126247) (← links)
- Advances in the management of glioblastoma: the role of temozolomide and MGMT testing (Q36500074) (← links)
- Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer (Q36625206) (← links)
- Multicenter phase II study of rituximab and temozolomide in recurrent primary central nervous system lymphoma (Q36712741) (← links)
- Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation--an International Primary Central Nervous System Lymphoma Study Group project (Q36805893) (← links)
- The role of whole brain radiation in primary CNS lymphoma (Q37141915) (← links)
- Recent advances in treatment of primary central nervous system lymphoma (Q37345440) (← links)
- Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options (Q37402645) (← links)
- Therapeutic challenges in primary CNS lymphoma (Q37484583) (← links)
- Methotrexate re-challenge for recurrent primary central nervous system lymphoma (Q37600487) (← links)
- Modern concepts in the biology, diagnosis, differential diagnosis and treatment of primary central nervous system lymphoma. (Q37911948) (← links)
- Management of elderly patients with primary central nervous system lymphoma (Q38096927) (← links)
- Diagnosis and treatment of primary CNS lymphoma (Q38106613) (← links)
- Retrospective study of pemetrexed as salvage therapy for central nervous system lymphoma (Q38119420) (← links)
- Combined modality therapy versus chemotherapy alone as an induction regimen for primary central nervous system lymphoma: a cost-effectiveness analysis (Q38209627) (← links)
- Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology (Q38543404) (← links)
- Late relapses in primary CNS lymphoma after complete remissions with high-dose methotrexate monotherapy (Q38617762) (← links)
- Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial (Q38824684) (← links)
- How I treat primary CNS lymphoma (Q39746438) (← links)
- Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network. (Q41139081) (← links)
- Current and emerging pharmacotherapies for primary CNS lymphoma (Q42126754) (← links)
- Salvage therapy for refractory AIDS-related primary central nervous system lymphoma (Q42632859) (← links)
- High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial (Q42849724) (← links)
- High-dose chemotherapy and autologous stem cell transplantation for secondary central nervous system lymphoma: many are called, but few are chosen (Q43181386) (← links)
- Initial experience with bendamustine in patients with recurrent primary central nervous system lymphoma: a case report. (Q44098314) (← links)
- High dose methotrexate for pediatric high grade glioma: results of the HIT-GBM-D Pilot study (Q48095838) (← links)
- Diagnosis and management of primary central nervous system lymphoma. (Q48095976) (← links)
- Stereotactic Radiosurgery in the Treatment of Recurrent CNS Lymphoma. (Q48232430) (← links)
- Salvage chemoimmunotherapy with rituximab, ifosfamide and etoposide (R-IE regimen) in patients with primary CNS lymphoma relapsed or refractory to high-dose methotrexate-based chemotherapy. (Q51295662) (← links)
- Treatment outcome of relapsed/refractory primary central nervous system diffuse large B-cell lymphoma: a single-center experience of autologous stem cell transplantation (Q51796882) (← links)
- Primary CNS Lymphoma. (Q51841565) (← links)
- Updates on Primary Central Nervous System Lymphoma. (Q52680296) (← links)
- Salvage therapy with bendamustine for methotrexate refractory recurrent primary CNS lymphoma: a retrospective case series. (Q53064246) (← links)
- The Diagnosis and Treatment of Primary CNS Lymphoma (Q56967801) (← links)
- Primary central nervous system lymphoma (Q57297768) (← links)
- Primary CNS lymphoma (Q59399605) (← links)
- Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred? (Q82954051) (← links)
- Review: Primary CNS lymphoma (Q83008900) (← links)
- Pemetrexed in the treatment of relapsed/refractory primary central nervous system lymphoma (Q83014385) (← links)
- Primary central nervous system lymphoma (Q85032508) (← links)
- Salvage radiotherapy in patients with recurrent or refractory primary or secondary central nervous system lymphoma after methotrexate-based chemotherapy (Q85175983) (← links)
- Treatment of primary CNS lymphoma (Q86958007) (← links)
- Prognostic impact of completion of initial high-dose methotrexate therapy on primary central nervous system lymphoma: a single institution experience (Q87659981) (← links)
- Case-based review: primary central nervous system lymphoma (Q92446494) (← links)